Pinnacle Wealth Planning Services’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.98K Sell
1,040
-511
-33% -$5K ﹤0.01% 2171
2026
Q2
$15.2K Buy
1,551
+20
+1% +$181 ﹤0.01% 1898
2026
Q1
$13K Buy
+1,531
New +$14.6K ﹤0.01% 1901

Other funds holding OCUL

Pinnacle Wealth Planning Services's OCUL Position: Q3 2026 in Review

Pinnacle Wealth Planning Services reduced its Ocular Therapeutix (OCUL) stake by 33% in Q3 2026, selling an estimated $5K and leaving 1,040 shares worth $7.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.

Pinnacle Wealth Planning Services first reported a position in OCUL in Q1 2026 and has held it in 3 quarters since. The position peaked at $15.2K in Q2 2026. 42 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Pinnacle Wealth Planning Services held 1,040 shares of Ocular Therapeutix worth $7.98K as of Q3 2026.
  • Pinnacle Wealth Planning Services sold 511 Ocular Therapeutix shares in Q3 2026, an estimated $5K.
  • Ocular Therapeutix made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #2171 holding.
  • Pinnacle Wealth Planning Services first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Ocular Therapeutix position peaked at $15.2K in Q2 2026.
  • 42 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.